PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. marinos.dalakas@jefferson.edu.\', \'Neuroimmunology Unit, Dept. of Pathophysiology, National and Kapodistrian University of Athens Medical School, Athens, Greece. marinos.dalakas@jefferson.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s13311-021-01108-4
?:doi
?:hasPublicationType
?:journal
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34766257
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34766257>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34766257>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all